Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
ET today
- ET today
CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced financial results for the first quarter ended March 31, 2024, and provided a business update. - Revenue was $12.5 million for the first quarter of 2024, as compared to $12.9 million in the first quarter of 2023.
- Net loss was $31.6 million for the first quarter of 2024, as compared to $27.4 million for the first quarter of 2023.
- ET to review the first quarter 2024 financial results and pipeline updates.